Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mymd Pharmaceuticals Inc MYMD

Healthcare
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro... see more

Recent & Breaking News (NDAQ:MYMD)

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akers Biosciences, Inc. – AKER

Business Wire June 13, 2018

Akers Shareholders: Bernstein Liebhard LLP Announces Investigation Of Akers Biosciences, Inc. - AKER

PR Newswire June 13, 2018

Report: Developing Opportunities within Energy Fuels, Barclays, Herbalife LTD, China Lodging Group, Eco-Stim Energy Solutions, and Akers Biosciences — Future Expectations, Projections Moving into 2018

GlobeNewswire June 7, 2018

Mid-Afternoon Market Update: J.Jill Climbs On Earnings Beat; Scpharmaceuticals Shares Fall

Benzinga.com  May 31, 2018

Mid-Day Market Update: Dow Down Over 250 Points; Madrigal Pharmaceuticals Shares Spike Higher

Benzinga.com  May 31, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com  May 31, 2018

Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement

GlobeNewswire May 30, 2018

Mid-Afternoon Market Update: Crude Oil Down 2.5%; American Woodmark Shares Spike Higher

Benzinga.com  May 29, 2018

Mid-Day Market Update: Dow Falls Over 400 Points; T2 Biosystems Shares Plunge

Benzinga.com  May 29, 2018

Akers Biosciences Announces a Change to the Board of Directors

GlobeNewswire May 29, 2018

Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation

GlobeNewswire May 29, 2018

Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq

GlobeNewswire May 25, 2018

Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test

GlobeNewswire April 12, 2018

Akers Biosciences Reports Earnings for Fiscal Year 2017

GlobeNewswire April 3, 2018

Akers Biosciences, Inc. to Host Earnings Call

Accesswire April 3, 2018

Earnings Scheduled For April 3, 2018

Benzinga.com  April 3, 2018

Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings

GlobeNewswire March 28, 2018

17 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  March 26, 2018

Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago

GlobeNewswire March 26, 2018

Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings

GlobeNewswire March 15, 2018